SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004284
Filing Date
2019-05-07
Accepted
2019-05-07 16:42:44
Documents
67
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20190331x10q.htm 10-Q 2121885
2 EX-31.1 knsa-20190331ex311e2e6a1.htm EX-31.1 12910
3 EX-31.2 knsa-20190331ex312e89027.htm EX-31.2 11753
4 EX-32.1 knsa-20190331ex321cae2d6.htm EX-32.1 7078
5 EX-32.2 knsa-20190331ex322d82011.htm EX-32.2 6966
  Complete submission text file 0001558370-19-004284.txt   6624577

Data Files

Seq Description Document Type Size
6 EX-101.INS knsa-20190331.xml EX-101.INS 1064172
7 EX-101.SCH knsa-20190331.xsd EX-101.SCH 53801
8 EX-101.CAL knsa-20190331_cal.xml EX-101.CAL 45680
9 EX-101.DEF knsa-20190331_def.xml EX-101.DEF 250492
10 EX-101.LAB knsa-20190331_lab.xml EX-101.LAB 458619
11 EX-101.PRE knsa-20190331_pre.xml EX-101.PRE 378924
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 19803721
SIC: 2834 Pharmaceutical Preparations